Ballentine Partners’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$81.3K	Buy	+23,689	New	+$81.3K	﹤0.01%	950
2025 Q1	–	Sell	-19,942	Closed	-$58.4K	–	912
2024 Q4	$58.4K	Sell	19,942 -790	-4%	-$2.32K	﹤0.01%	868
2024 Q3	$53.9K	Buy	+20,732	New	+$53.9K	﹤0.01%	832